Jardine Matheson — $J36 (-1.79%)
Assessment
Reference price: ~US$62–63
Score:
81/100
Rating: 🟢 BUY
Fair Value:
~US$80
Bear Case: ~US$58
Bull Case: ~US$95
1. Business Quality — 78/100
Jardine Matheson is a high-quality investment holding company, but not a pure compounder.
Key strengths:
- High-quality assets including Astra, Jardine Cycle & Carriage, Hongkong Land, DFI and Mandarin Oriental.
- Strong balance sheet at the holding level.
- Improving capital allocation.
- Increasing focus on recycling capital toward higher-return opportunities.
- New investment platform through I-MED.
Main weaknesses:
- Complex holding structure.
- Significant exposure to Indonesia and property.
- Astra remains a major earnings contributor.
- Historical shareholder returns have not yet demonstrated exceptional compounding.
2. 1H26 Fundamentals
The latest results support the investment thesis:
- Underlying profit: US$735M, +9%
- Adjusted EPS: US$2.50, +8%
- Parent free cash flow: US$709M, +21%
- Parent net cash: US$379M
- Interim dividend: US$0.65, +8%
- Capital recycled in 1H26: ~US$1.5B
The company is also targeting:
- ≥9% annual TSR through 2030
- ≥5% annual dividend growth
- ≥US$4B of capital recycling
- US$500M share buyback programme
This represents a meaningful improvement in capital allocation discipline.
3. Reinvestment Runway — 82/100
This is one of the strongest aspects of the v2.2 thesis.
Jardine has significant capacity to:
- recycle mature assets;
- reinvest in higher-return businesses;
- repurchase undervalued shares;
- build new platforms.
I-MED is strategically interesting, but its future contribution should not yet be heavily included in valuation until execution is demonstrated.
4. Valuation
Jardine should not be valued purely on P/E.
A normalized EPS assumption of approximately US$5.1–5.4 supports a reasonable earnings valuation of roughly US$65–80.
The SOTP/NAV approach provides additional support. Shareholders’ funds were approximately US$28.5B at June 2026, although accounting book value should not be treated as equivalent to economic NAV.
The combination of:
- quality assets;
- strong cash generation;
- capital recycling;
- buybacks;
- and a persistent holding-company discount
supports a central fair value of approximately:
US$80 per share
5. Valuation Range
Scenario
Value
Bear
US$58
Conservative
US$70
Base / Fair Value
US$80
Bull
US$95
At ~US$62–63, the shares offer approximately 27–29% upside to fair value.
6. IPIS v2.2 Score
Factor
Score
Business Quality
78
Valuation
88
Margin of Safety
82
FCF
84
Balance Sheet
86
Capital Allocation
88
Reinvestment Runway
82
Growth
69
Moat / Asset Quality
78
81/100
🟢 Final Decision: BUY
Buy zone: < US$65
Strong Buy: < US$55
Fair Value: ~US$80
Watch / Hold: US$72–80
Avoid: > US$90
Investment thesis
Jardine Matheson is best viewed as a quality investment holding undergoing a capital-allocation transformation, rather than as an exceptional operating compounder.
At ~US$62–63, the valuation provides enough margin of safety to compensate for the holding structure, business complexity and execution risks.
ConclusionF: BUY — 81/100.